Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Updates in Surgery
Erschienen in: Updates in Surgery 2/2017

13.06.2017 | Review Article

Surgical approach to level VI in papillary thyroid carcinoma: an overview

verfasst von: Carmela De Crea, Marco Raffaelli, Luca Sessa, Celestino Pio Lombardi, Rocco Bellantone

Erschienen in: Updates in Surgery | Ausgabe 2/2017

Einloggen, um Zugang zu erhalten

Abstract

One of the most controversial issues in the treatment of thyroid cancer is the management of the central neck nodes in patients with papillary thyroid carcinoma (PTC). Lymph node involvement is common in patients with PTC and it may negatively affect recurrence rate and, probably, survival. Although therapeutic compartment-oriented central neck dissection is the standard treatment for patients with clinical nodal involvement (cN1) PTC, the role and the extension for elective or prophylactic central neck dissection (PCND) in patients with clinically node negative (cN0) neoplasms remains controversial. In recent years, in order to decrease the risk of postoperative complications related to PCND, unilateral central neck dissection has emerged as an alternative approach to bilateral central neck dissection.
Literatur
1.
McLeod DS, Sawka AM, Cooper DS (2013) Controversies in primary treatment of low-risk papillary thyroid cancer. Lancet 381:1046–1057CrossRefPubMed
2.
Shan CX, Zhang W, Jiang DZ, Zheng XM, Liu S, Qui M (2012) Routine central neck dissection in differentiated thyroid carcinoma: a systematic review and meta-analysis. Laryngoscope 122:797–804CrossRefPubMed
3.
White ML, Gauger PG, Doherty GM (2007) Central lymph node dissection in differentiated thyroid cancer. World J Surg 31:895–904CrossRefPubMed
4.
Sippel RS, Chen H (2009) Controversies in the surgical management of newly diagnosed and recurrent/residual thyroid cancer. Thyroid 19:1373–1380CrossRefPubMed
5.
Lang BH, Ng SH, Lau L, Cowling B, Wong KP, Whan KY (2013) A systematic review and meta-analysis of prophylactic central neck dissection on short-term locoregional recurrence in papillary thyroid carcinoma after total thyroidectomy. Thyroid 23:1087–1098CrossRefPubMed
6.
Liang J, Li Z, Fang F, Yu T, Li S (2017) Is prophylactic central neck dissection necessary for cN0 differentiated thyroid cancer patients at initial treatment? A meta-analysis of the literature. Acta Otorhinolaryngol Ital 37:1–8PubMedPubMedCentral
7.
Carty SE, Cooper DS, Doherty GM et al (2009) Consensus statement on the terminology and classification of central neck dissection for thyroid cancer. Thyroid 19:1153–1158CrossRefPubMed
8.
Haugen BR, Alexander EK, Bible KC et al (2016) 2015 American Thyroid Association Management Guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid 26:1–133CrossRefPubMedPubMedCentral
9.
Perros P, Boelaert K, Colley S et al (2014) British Thyroid Association. Guidelines for the management of thyroid cancer. Clin Endocrinol (Oxf) 81(Suppl 1):1–122CrossRef
10.
Sancho JJ, Lennard TW, Paunovic I et al (2014) Prophylactic central neck dissection in papillary thyroid cancer: a consensus report of the European Society of Endocrine Surgeons (ESES). Langenbecks Arch Surg 399:155–163CrossRefPubMed
11.
Barczynski M, Konturek A, Stopa M, Nowak W (2013) Prophylactic central neck dissection for papillary thyroid cancer. Br J Surg 100:410–418CrossRefPubMed
12.
Giordano D, Valcavi R, Thompson GB, Pedroni C, Renna L, Gradoni P et al (2012) Complications of central neck dissection in patients with papillary thyroid carcinoma: results of a study on 1087 patients and review of the literature. Thyroid 22:911–917CrossRefPubMed
13.
Sadowski BM, Snyder SK, Lairmore TC (2009) Routine bilateral central lymph node clearance for papillary thyroid cancer. Surgery 146:696–705CrossRefPubMed
14.
Shaha AR (2009) Prophylactic central compartment dissection in thyroid cancer: a new avenue of debate. Surgery 146:1224–1227CrossRefPubMed
15.
Hughes DT, White ML, Miller BS, Gauger PG, Burney RE, Doherty GM (2010) Influence of prophylactic central lymph node dissection on postoperative thyroglobulin levels and radioiodine treatment in papillary thyroid cancer. Surgery 148:1100–1106CrossRefPubMed
16.
Cisco RM, Shen WT, Gosnell JE (2012) Extent of surgery for papillary thyroid cancer: preoperative imaging and role of prophylactic and therapeutic neck dissection. Curr Treat Options Oncol 13:1–10CrossRefPubMed
17.
Carling T, Long WD III, Udelsman R (2010) Controversy surrounding the role for routine central lymph node dissection for differentiated thyroid cancer. Curr Opin Oncol 22:30–34CrossRefPubMed
18.
Moo TS, Umunna B, Kato M et al (2009) Ipsilateral versus bilateral central neck lymph node dissection in papillary thyroid carcinoma. Ann Surg 250:403–408PubMed
19.
Chae BJ, Jung CK, Lim DJ, Song BJ, Kim JS, Jung SS, Bae JS (2011) Performing contralateral central lymph node dissection in papillary thyroid carcinoma: a decision approach. Thyroid 21:873–877CrossRefPubMed
20.
Raffaelli M, De Crea C, Sessa L, Giustacchini P, Revelli L, Bellantone C, Lombardi CP (2012) Prospective evaluation of total thyroidectomy versus ipsilateral versus bilateral central neck dissection in patients with clinically node negative papillary thyroid carcinoma. Surgery 152:957–964CrossRefPubMed
21.
Raffaelli M, De Crea C, Sessa L, Giustacchini P, Bellantone R, Lombardi CP (2013) Can intraoperative frozen section influence the extension of central neck dissection in cN0 papillary thyroid carcinoma? Langenbecks Arch Surg 398:383–388CrossRefPubMed
22.
Raffaelli M, De Crea C, Sessa L et al (2015) Ipsilateral central neck dissection plus frozen section examination versus prophylactic bilateral central neck dissection in cN0 papillary thyroid carcinoma. Ann Surg Oncol 22:2302–2308CrossRefPubMed
23.
Viola D, Materazzi G, Valerio L et al (2015) Prophylactic central compartment lymph node dissection in papillary thyroid carcinoma: clinical implications derived from the first prospective randomized controlled single institution study. J Clin Endocrinol Metab 100:1316–1324CrossRefPubMed
24.
Calò PG, Conzo G, Raffaelli M et al (2017) Total thyroidectomy alone versus ipsilateral versus bilateral prophylactic central neck dissection in clinically node-negative differentiated thyroid carcinoma. A retrospective multicenter study. Eur J Surg Oncol 43:126–132CrossRefPubMed
25.
Son YI, Jeong HS, Baek CH et al (2008) Extent of prophylactic lymph node dissection in the central neck area of the patients with papillary thyroid carcinoma: comparison of limited versus comprehensive lymph node dissection in a 2-year safety study. Ann Surg Oncol 15:2020–2026CrossRefPubMed
26.
Koo BS, Choi EC, Yoon YH, Kim DH, Kim EH, Lim YC (2009) Predictive factors for ipsilateral or contralateral central lymph node metastasis in unilateral papillary thyroid carcinoma. Ann Surg 249:840–844CrossRefPubMed
27.
Bellantone R, Lombardi CP, Raffaelli M et al (2003) Video-assisted thyroidectomy for papillary thyroid carcinoma. Surg Endosc 17:1604–1608CrossRefPubMed
28.
Lombardi CP, Raffaelli M, de Crea C et al (2007) Report on 8 years of experience with video-assisted thyroidectomy for papillary thyroid carcinoma. Surgery 142:944–951CrossRefPubMed
29.
Miccoli P, Elisei R, Materazzi G et al (2002) Minimally invasive video-assisted thyroidectomy for papillary carcinoma: a prospective study of its completeness. Surgery 132:1070–1074CrossRefPubMed
30.
Bellantone R, Lombardi CP, Raffaelli M et al (2002) Central neck lymph node removal during minimally invasive video-assisted thyroidectomy for thyroid carcinoma: a feasible and safe procedure. J Laparoendosc Adv Surg Tech A 12:181–185CrossRefPubMed
31.
Lombardi CP, Raffaelli M, De Crea C et al (2012) Video-assisted versus conventional total thyroidectomy and central compartment neck dissection for papillary thyroid carcinoma. World J Surg 36:1225–1230CrossRefPubMed
32.
Podnos YD, Smith D, Wagman LD, Ellenhorn JD (2005) The implication of lymph node metastasis on survival in patients with well-differentiated thyroid cancer. Am Surg 71:731–734PubMed
33.
Leboulleux S, Rubino C, Baudin E et al (2005) Prognostic factors for persistent or recurrent disease of papillary thyroid carcinoma with neck lymph node metastases and/or tumor extension beyond the thyroid capsule at initial diagnosis. J Clin Endocrinol Metab 90:5723–5729CrossRefPubMed
34.
Sugitani I, Kasai N, Fujimoto Y, Yanagisawa A (2004) A novel classification system for patients with PTC: addition of the new variables of large (3 cm or greater) nodal metastases and reclassification during the follow-up period. Surgery 135:139–148CrossRefPubMed
35.
Adam MA, Pura J, Goffredo P et al (2015) Presence and number of lymph node metastases are associated with compromised survival for patients younger than age 45 years with papillary thyroid cancer. J Clin Oncol 33:2370–2375CrossRefPubMed
36.
Randolph GW, Duh QY, Heller KS et al (2012) The prognostic significance of nodal metastases from papillary thyroid carcinoma can be stratified based on the size and number of metastatic lymph nodes, as well as the presence of extranodal extension. Thyroid 22:1144–1152CrossRefPubMed
37.
Carling T, Carty SE, Ciarleglio MM, Cooper DS, Doherty GM, Kim LT et al (2012) American Thyroid Association design and feasibility of a prospective randomized controlled trial of prophylactic central lymph node dissection for papillary thyroid carcinoma. Thyroid 22:237–244CrossRefPubMed
38.
Shen WT, Ogawa L, Ruan D et al (2010) Central neck lymph node dissection for papillary thyroid cancer: the reliability of surgeon judgment in predicting which patients will benefit. Surgery 148:398–403CrossRefPubMed
39.
Mazzaferri EL, Doherty GM, Steward DL (2009) The pros and cons of prophylactic central compartment lymph node dissection for papillary thyroid carcinoma. Thyroid 19:683–689CrossRefPubMed
40.
Zuniga S, Sanabria A (2009) Prophylactic central neck dissection in stage N0 papillary thyroid carcinoma. Arch Otolaryngol Head Neck Surg 135:1087–1091CrossRefPubMed
41.
Blanchard C, Brient C, Volteau C et al (2013) Factors predictive of lymph node metastasis in the follicular variant of papillary thyroid carcinoma. Br J Surg 100:1312–1317CrossRefPubMed
42.
Cranshaw IM, Carnaille B (2008) Micrometastases in thyroid cancer. An important finding? Surg Oncol 17:253–258CrossRefPubMed
Metadaten
Titel
Surgical approach to level VI in papillary thyroid carcinoma: an overview
verfasst von
Carmela De Crea
Marco Raffaelli
Luca Sessa
Celestino Pio Lombardi
Rocco Bellantone
Publikationsdatum
13.06.2017
Verlag
Springer Milan
Erschienen in
Updates in Surgery / Ausgabe 2/2017
Print ISSN: 2038-131X
Elektronische ISSN: 2038-3312
DOI
https://doi.org/10.1007/s13304-017-0468-2

Weitere Artikel der Ausgabe 2/2017

Updates in Surgery 2/2017 Zur Ausgabe

Original Article

Role of prophylactic central neck dissection in clinically node-negative differentiated thyroid cancer: assessment of the risk of regional recurrence

Original Article

Risk factors for postoperative hypocalcemia

Review Article

Surgical management of papillary thyroid carcinoma: an overview

Review Article

Video-assisted endocrine neck surgery: state of the art

Review Article

Neuromonitoring in endoscopic and robotic thyroidectomy

Review Article

Robot-assisted adrenalectomy: indications and drawbacks

Neu im Fachgebiet Chirurgie

23.04.2024 | Ablationstherapie | Nachrichten

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

23.04.2024 | Appendizitis | Nachrichten

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 | Operationsvorbereitung | Nachrichten

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

19.04.2024 | EAU 2024 | Kongressbericht | Nachrichten

Ureterstriktur: Innovative OP-Technik bewährt sich
weitere anzeigen

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Aktuelle BDC Leitlinien-Webinare

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.